Empire Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Empire Genomics's estimated annual revenue is currently $4.3M per year.
- Empire Genomics's estimated revenue per employee is $206,667
- Empire Genomics's total funding is $3.3M.
- Empire Genomics has 21 Employees.
- Empire Genomics grew their employee count by -9% last year.
Empire Genomics Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Empire Genomics?
Empire Genomics was created in 2006 from research started at the prestigious Roswell Park Cancer Institute in Buffalo, New York. The laboratory has a strong track record in the development of high throughput technologies to enable genome-wide analyses aimed at determining the underlying mechanisms for diseases. Having played a fundamental role in the Human Genome Project and created the foundational Bacterial Artificial Chromosomes which served as the basis for sequencing the genome, Empire's lab developed significant expertise in genomic research. It is from this strong experiential base that we bring our capabilities, tools and techniques to support the research, clinical and drug discovery global community. Realizing the possibility of where genomics tools will take medicine is not difficult to see, however for this potential to become reality will take genomic solutions which are robust and permit the high resolution detection of genomic aberrations and their corresponding correlations to underlying phenotypes. Traditionally the field has been plagued with immature technological tools with too much inconsistency, no customization and uncontrollable variability. Empire Genomics is excited to bring its expertise to bear on these challenges. Empire Genomics is committed to working with the scientific community to bring the best in genomic technologies to bear on the complex systems biology questions that we collectively seek to answer. We will continually work to remove costly variation, inconsistency and the lack of reproducibility that has prevented the field from rapidly moving forward with discoveries.keywords:Biotechnology
Number of Employees
Employee Growth %
Empire Genomics News
Bayer AG, Teva Pharmaceuticals, Empire Genomics, LLC. SeraCare Life Sciences F. Hoffmann-La Roche Ltd NeoGenomics Laboratories, Inc.
... various techniques such as comparative genomic hybridization, ... Inc., Empire Genomics, LLC, Irvine Scientific, PerkinElmer, Inc.,...
... Applied Spectral Imaging, Empire Genomics, Inc.., Illumina, Inc., PerkinElmer Inc., Sysmex Corporation, Thermo Fisher Scientific Inc.,...
Empire Genomics, a Buffalo, NY-based molecular diagnostics company, raised $1.75m financing round. The round was led by existing investor BroadOak Capital Partners with participation from Rand Capital Corporation (NASDAQ: RAND). The company will use the proceeds to continue growing its busines ...
The company has been planning for some time now to grow its employee count — it announced a five-year plan in 2012 to add 50 new workers to its offices that border the Buffalo Niagara Medical Campus. Earlier this year, Empire Genomics was included in a $105 million genomic research consortium f ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|